Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hemorrhage 2Hematologic Neoplasms 2Thrombocytopenia 1Postoperative Hemorrhage 1Pelvic Mass 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Colonic Neoplasms 1Breast Neoplasms 1Breast Cancer Females 1Brain Neoplasms 1

Interventions

Fulvestrant 125Trastuzumab 115Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Anastrozole 72Capecitabine 71Cyclophosphamide 69Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 61trastuzumab deruxtecan 58Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 48Magnetic Resonance Spectroscopy 48Docetaxel 48Blood Specimen Collection 40olaparib 39Standard of Care 37Biopsy 34sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Exercise 29Doxorubicin 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Tranexamic Acid × 1 year × Clear all
NCT05807074 2025-09-29

Impact of Topical Tranexamic Acid in Breast Reconstruction

University of California, San Francisco

Phase 4 Terminated
23 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡